Skip to main content

Featured

Mojtaba Khamenei’s Rise Sparks Market Turmoil as Hardliners Mobilize

People attend a gathering to support Iran's new supreme leader Mojtaba Khamenei, amid the U.S.-Israeli conflict with Iran, in Tehran, Iran, March 9, 2026.  Iran’s hardline factions mounted a powerful show of support for newly appointed Supreme Leader Mojtaba Khamenei , rallying across Tehran in a display that signaled a tightening of conservative control and diminished hopes for de-escalation in the Middle East.  The demonstrations, marked by mass gatherings and imagery linking Mojtaba to his late father, Ayatollah Ali Khamenei, underscored the regime’s consolidation at a moment of heightened regional conflict.  Analysts warn that the hardliners’ unified backing suggests Iran is unlikely to soften its stance amid ongoing tensions with the U.S. and Israel. Global markets reacted sharply. Fears that prolonged instability could further disrupt energy supplies sent oil prices soaring and triggered steep declines in major stock indices. With one of the most significan...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment